CMS issues proposed decision memorandum for screening for cervical cancer with testing
Physician Practice Insider, May 5, 2015
On April 16, CMS posted a proposed decision memorandum stating evidence is sufficient to add Human Papillomavirus (HPV) testing once every five years as an additional preventive service benefit under the Medicare program for asymptomatic beneficiaries aged 30 to 65 years in conjunction with the pap smear test. CMS will cover screening for cervical cancer with the appropriate FDA-approved/cleared laboratory tests, used consistent with FDA-approved labeling and in compliance with the CLIA regulations.
View the proposed decision memorandum.
This article originally appeared in Medicare Weekly Insider.
Related Products
Most Popular
- Articles
-
- CMS seeks comment on quality measures
- Practice the six rights of medication administration
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- ICD-10-CM coma, stroke codes require more specific documentation
- Nursing responsibilities for managing pain
- OB services: Coding inside and outside of the package
- Q&A: Primary, principal, and secondary diagnoses
- Clearing up the confusion: CPT codes 76376 and 76377
- CMS creates web portal for questions about 1135 waivers, PHE
- E-mailed
-
- Coronavirus vaccination: 4 best practices for communicating with patients
- Grievances, Complaints, and Patients’ Rights
- Including 46600 in E/M leveling systems
- How to get reimbursed for restorative nursing
- Five keys to creating a CHF disease management program
- Fetal non-stress tests represent important part of maternal and fetal health
- Coding, billing, and documentation tips for teaching physicians, interns, residents, and students
- Coding tip: Know how to correctly code each procedure an otolaryngologist can perform on turbinates
- Coding Clinic reiterates guidelines for provider documentation
- CMS creates web portal for questions about 1135 waivers, PHE
- Searched